Johnson & Johnson (JNJ)
148.53
-1.03
(-0.69%)
USD |
NYSE |
Apr 24, 16:00
148.80
+0.27
(+0.18%)
Pre-Market: 06:46
Johnson & Johnson Price to Book Value: 5.204 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 5.204 |
| April 23, 2024 | 5.240 |
| April 22, 2024 | 5.225 |
| April 19, 2024 | 5.183 |
| April 18, 2024 | 5.107 |
| April 17, 2024 | 5.073 |
| April 16, 2024 | 5.061 |
| April 15, 2024 | 5.171 |
| April 12, 2024 | 5.169 |
| April 11, 2024 | 5.214 |
| April 10, 2024 | 5.263 |
| April 09, 2024 | 5.336 |
| April 08, 2024 | 5.312 |
| April 05, 2024 | 5.340 |
| April 04, 2024 | 5.344 |
| April 03, 2024 | 5.405 |
| April 02, 2024 | 5.527 |
| April 01, 2024 | 5.528 |
| March 31, 2024 | |
| March 28, 2024 | 5.543 |
| March 27, 2024 | 5.535 |
| March 26, 2024 | 5.458 |
| March 25, 2024 | 5.439 |
| March 22, 2024 | 5.439 |
| March 21, 2024 | 5.457 |
| Date | Value |
|---|---|
| March 20, 2024 | 5.458 |
| March 19, 2024 | 5.474 |
| March 18, 2024 | 5.493 |
| March 15, 2024 | 5.542 |
| March 14, 2024 | 5.579 |
| March 13, 2024 | 5.645 |
| March 12, 2024 | 5.702 |
| March 11, 2024 | 5.649 |
| March 08, 2024 | 5.589 |
| March 07, 2024 | 5.567 |
| March 06, 2024 | 5.583 |
| March 05, 2024 | 5.605 |
| March 04, 2024 | 5.601 |
| March 01, 2024 | 5.680 |
| February 29, 2024 | 5.655 |
| February 28, 2024 | 5.661 |
| February 27, 2024 | 5.641 |
| February 26, 2024 | 5.632 |
| February 23, 2024 | 5.668 |
| February 22, 2024 | 5.620 |
| February 21, 2024 | 5.558 |
| February 20, 2024 | 5.529 |
| February 16, 2024 | 5.483 |
| February 15, 2024 | 5.531 |
| February 14, 2024 | 5.455 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.921
Minimum
Oct 27 2023
7.092
Maximum
Jan 26 2021
6.020
Average
6.057
Median
Jul 01 2019
Price to Book Value Benchmarks
| Amgen Inc | 23.48 |
| Gilead Sciences Inc | 3.660 |
| Eli Lilly and Co | 64.63 |
| Merck & Co Inc | 8.559 |
| Shockwave Medical Inc | 18.39 |
Price to Book Value Related Metrics
| PE Ratio | 10.36 |
| PS Ratio | 4.157 |
| PEG Ratio | 0.0518 |
| Price | 148.53 |
| Earnings Yield | 9.65% |
| Market Cap | 357.93B |
| PEGY Ratio | 0.051 |
| Operating PE Ratio | 16.13 |
| Normalized PE Ratio | 18.15 |